Innovent Biologics Inc.

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

PMV’s $79.4m cash pile now hinges on rezatapopt’s 2027 ovarian cancer FDA bid

NFI Group’s backlog shrank 10.6% as earnings surged. How can both be true?

Frontera Energy’s post-divestment strategy is shifting toward infrastructure growth, with Puerto Bahía, its ODL pipeline stake and a planned LNG regasification project expected to drive future cash flow after the company returned C$590 million to shareholders. Representative image.

Frontera Energy (TSX: FEC) Q2 puts early-2027 LNG launch in focus

Shell’s Wild Coast offshore exploration plans have suffered a major setback after South Africa’s Constitutional Court blocked the disputed exploration right, sharpening scrutiny of how the country balances energy investment with environmental safeguards and community consultation. Representative image.

Shell plc (LSE: SHEL) blocked from Wild Coast exploration as South Africa faces investment test

OPKO Health (Nasdaq: OPK) raises $125m against mazdutide royalties as GLP-1 financing strategy deepens

OPKO Health raises $125 million against mazdutide royalties. Read how the KKR-linked financing reshapes OPK’s GLP-1 capital strategy.

byVenkatesh

August 14, 2026

Biotech laboratory image illustrating Spero Therapeutics’ shift from Utebzi antibiotic approval to a royalty-funded SP001 immunology strategy. Representative image.

Spero Therapeutics (Nasdaq: SPRO) pivots to immunology after Utebzi approval and $105m financing

Spero Therapeutics uses Utebzi royalties to fund an Innovent immunology pivot. Read how SPRO’s cash runway, CD40L bet and stock discount fit together.

bySrinath

August 13, 2026

The Latest

PMV’s $79.4m cash pile now hinges on rezatapopt’s 2027 ovarian cancer FDA bid

NFI Group’s backlog shrank 10.6% as earnings surged. How can both be true?

Frontera Energy (TSX: FEC) Q2 puts early-2027 LNG launch in focus

Shell plc (LSE: SHEL) blocked from Wild Coast exploration as South Africa faces investment test

OPKO Health (Nasdaq: OPK) raises $125m against mazdutide royalties as GLP-1 financing strategy deepens

PMV’s $79.4m cash pile now hinges on rezatapopt’s 2027 ovarian cancer FDA bid

NFI Group’s backlog shrank 10.6% as earnings surged. How can both be true?

Frontera Energy (TSX: FEC) Q2 puts early-2027 LNG launch in focus

Shell plc (LSE: SHEL) blocked from Wild Coast exploration as South Africa faces investment test

Polish pilgrim bus crash kills 12 in Hungary as driver fatigue becomes focus of M3 investigation

New Alzheimer’s imaging approval could help unlock Lantheus’ neurology merger payouts

Standard Bank (JSE: SBK) profit rises 10% despite margin pressure as Africa growth bet enters new phase

Grasim Q1 adjusted profit jumps 49% as Birla Opus and Birla Pivot scale, but net debt rises